OIG Report: Part B Drug Payments Included Noncovered Self-Administered Versions, Increasing Costs

Thu, 26 Mar 2026 19:14:29 +0000
Healthcare

An HHS OIG report found that Medicare Part B payment amounts for the drug Omvoh included noncovered self-administered versions in 2024, increasing costs. Excluding these versions would have saved Part B and its enrollees an estimated $1,742 per vial in the fourth quarter of 2024. The report also noted that CMS's prior removal of noncovered self-administered versions for five other drugs saved $1.3 billion from 2023 through 2024.